Abingdon Health Plc Stock Performance
| ABDXF Stock | USD 0.07 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Abingdon Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abingdon Health Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Abingdon Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5 M | |
| Total Cashflows From Investing Activities | -756 K |
Abingdon |
Abingdon Health Relative Risk vs. Return Landscape
If you would invest 7.00 in Abingdon Health Plc on October 13, 2025 and sell it today you would earn a total of 0.00 from holding Abingdon Health Plc or generate 0.0% return on investment over 90 days. Abingdon Health Plc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Abingdon, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Abingdon Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abingdon Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Abingdon Health Plc, and traders can use it to determine the average amount a Abingdon Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ABDXF |
Based on monthly moving average Abingdon Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abingdon Health by adding Abingdon Health to a well-diversified portfolio.
Abingdon Health Fundamentals Growth
Abingdon Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Abingdon Health, and Abingdon Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abingdon Pink Sheet performance.
| Return On Equity | -1.53 | |||
| Return On Asset | -0.32 | |||
| Operating Margin | (4.19) % | |||
| Current Valuation | 5.33 M | |||
| Shares Outstanding | 121.72 M | |||
| Price To Book | 0.33 X | |||
| Price To Sales | 3.31 X | |||
| Revenue | 2.83 M | |||
| EBITDA | (12.7 M) | |||
| Cash And Equivalents | 5.96 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 435 K | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (7.74 M) | |||
| Total Asset | 12.77 M | |||
About Abingdon Health Performance
By analyzing Abingdon Health's fundamental ratios, stakeholders can gain valuable insights into Abingdon Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Abingdon Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abingdon Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom. Abingdon Health operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 123 people.Things to note about Abingdon Health Plc performance evaluation
Checking the ongoing alerts about Abingdon Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Abingdon Health Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abingdon Health Plc generated a negative expected return over the last 90 days | |
| Abingdon Health Plc has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.83 M. Net Loss for the year was (21.26 M) with loss before overhead, payroll, taxes, and interest of (3.59 M). | |
| Abingdon Health Plc has accumulated about 5.96 M in cash with (7.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 54.0% of the company shares are held by company insiders |
- Analyzing Abingdon Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abingdon Health's stock is overvalued or undervalued compared to its peers.
- Examining Abingdon Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abingdon Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abingdon Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abingdon Health's pink sheet. These opinions can provide insight into Abingdon Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Abingdon Pink Sheet analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |